Potential for epistemic injustice in evidence-based healthcare policy and guidance

Strength of public preferences for endovascular or open aortic aneurysm repair

(2019) N. Wickramasekera et al.   BRITISH JOURNAL OF SURGERY

OUP accepted manuscript

(2018)   RHEUMATOLOGY

Valuing health-related quality of life: An EQ-5D-5L value set for England

(2017) Nancy J. Devlin et al.   HEALTH ECONOMICS

Outcome reporting bias in clinical trials: why monitoring matters

(2017) John PA Ioannidis et al.   BMJ-British Medical Journal

Outcome reporting bias in clinical trials: why monitoring matters

(2017) John PA Ioannidis et al.   BMJ-British Medical Journal

Surrogate End Points and Their Validation in Oncology Clinical Trials

(2016) Fengmin Zhao   JOURNAL OF CLINICAL ONCOLOGY

Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients

(2016) J Mossman et al.   VALUE IN HEALTH

Planning and reporting of quality-of-life outcomes in cancer trials

(2015) S. Schandelmaier et al.   ANNALS OF ONCOLOGY

Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients

(2015) Aliasghar A. Kiadaliri et al.   Health and Quality of Life Outcomes

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial

(2015) Janesh K Gupta et al.   HEALTH TECHNOLOGY ASSESSMENT

The limited impact of indeterminacy for healthcare rationing: how indeterminacy problems show the need for a hybrid theory, but nothing more

(2015) Anders Herlitz   JOURNAL OF MEDICAL ETHICS

The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer

(2014) Tom Treasure et al.   BMJ Open

Innovative Payment Models and Measurement for Cancer Therapy

(2014) Lee N. Newcomer   Journal of Oncology Practice

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparator bias: why comparisons must address genuine uncertainties

(2013) Howard Mann et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Pharma fines increase, but the pain is not felt on Wall Street

(2013) Susan Matthews   NATURE MEDICINE

The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions

(2013) Roderik F. Viergever   Global Health Action

Restoring invisible and abandoned trials: a call for people to publish the findings

(2013) P. Doshi et al.   BMJ-British Medical Journal

The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure

(2011) Antonio Cherubini et al.   ARCHIVES OF INTERNAL MEDICINE

Intergenerational equity and the social discount rate

(2011) Helen Scarborough   AUSTRALIAN JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS

EQ-5D as a Quality of Life Measure in People with Dementia and Their Carers: Evidence and Key Issues

(2011) Natalia Hounsome et al.   VALUE IN HEALTH

Is the EQ–5D fit for purpose in mental health?

(2010) John Brazier   BRITISH JOURNAL OF PSYCHIATRY

Discounting and decision making in the economic evaluation of health-care technologies

(2010) Karl Claxton et al.   HEALTH ECONOMICS

Justice and procedure: how does "accountability for reasonableness" result in fair limit-setting decisions?

(2008) A Rid   JOURNAL OF MEDICAL ETHICS

The Problem With Composite End Points in Cardiovascular Studies

(2008) Kevin E. Kip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet

(2008) Sanaa Al-Marzouki et al.   LANCET